United States · FDA National Drug Code directory
Depo-Medrol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0009-0280_267dd735-f800-4735-ba1c-d39d00f0cee5
- Product NDC
- 0009-0280
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- methylprednisolone acetate
- Labeler
- Pharmacia & Upjohn Company LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19590528
- Source listing expiry
- 20271231
Source-listed ingredients
- METHYLPREDNISOLONE ACETATE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (0009-0280-02) / 5 mL in 1 VIAL, MULTI-DOSE · 0009-0280-02
- 10 mL in 1 VIAL, MULTI-DOSE (0009-0280-03) · 0009-0280-03
- 25 VIAL, MULTI-DOSE in 1 PACKAGE (0009-0280-51) / 5 mL in 1 VIAL, MULTI-DOSE · 0009-0280-51
- 25 VIAL, MULTI-DOSE in 1 PACKAGE (0009-0280-52) / 10 mL in 1 VIAL, MULTI-DOSE · 0009-0280-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →